May 13, 2020
Neurocrine Biosciences to Present Data from its Movement Disorder Portfolio on the American Academy of Neurology Science Highlights Platform
Apr 27, 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS® (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Apr 03, 2020
Neurocrine Biosciences Provides COVID-19 Business Update
Nov 04, 2019
Neurocrine Biosciences Reports Third Quarter 2019 Financial Results
Sep 17, 2019
Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) for Tardive Dyskinesia; Opicapone and VY-AADC for Parkinson's Disease, at the 2019 International Congress of Parkinson's Disease and Movement Disorders®
Jul 29, 2019
Neurocrine Biosciences Reports Second Quarter 2019 Financial Results
Jul 10, 2019
Neurocrine Biosciences Announces FDA Acceptance of New Drug Application for Opicapone as an Adjunctive Treatment for Patients with Parkinson's Disease
Jun 11, 2019
Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2019 World Congress on Parkinson's Disease and Related Disorders
Apr 30, 2019
Neurocrine Biosciences to Present Data Analyses on INGREZZA® (valbenazine) and Opicapone at the 2019 American Academy of Neurology Annual Meeting
Apr 08, 2019
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2019 Financial Results
Mar 05, 2019
Neurocrine Biosciences to Present at Upcoming Healthcare Conferences
Feb 05, 2019
Neurocrine Biosciences Reports Fourth Quarter and Year-End 2018 Financial Results
Jan 15, 2019
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2018 Financial Results
Jan 06, 2019
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2018 Net Product Sales Results and 2019 Program Milestones
Jan 02, 2019
Neurocrine Biosciences to Present at the 37th Annual J.P. Morgan Healthcare Conference
Nov 07, 2018
Neurocrine Biosciences to Present at the Jefferies 2018 London Healthcare Conference
Nov 05, 2018
Neurocrine Biosciences Reports Third Quarter 2018 Financial Results
Oct 15, 2018
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2018 Financial Results
Oct 09, 2018
Neurocrine Biosciences and Jnana Therapeutics Enter Strategic Collaboration to Discover Novel Medicines to Treat Central Nervous System Disorders
Sep 05, 2018
Neurocrine Biosciences to Present at the Morgan Stanley 16th Annual Global Healthcare Conference